The global prevalence of obesity and overweight is increasing rapidly among adults as well as among children and adolescents. Recent genome-wide association studies have provided strong support for association between variants in the FTO gene and obesity. We sequenced regions of the FTO gene to identify novel variants that are associated with obesity and related metabolic traits. Results: We screened exons 3 and 4 including exon-intron boundaries in FTO in 48 obese children and adolescents and identified three novel single nucleotide polymorphism in the fourth intronic region, (c.896 þ 37A4G, c.896 þ 117C4G and c.896 þ 223A4G). We further genotyped c.896 þ 223A4G in 962 subjects, 450 well-characterized obese children and adolescents and 512 adolescents with normal weight. Evidence for differences in genotype frequencies were not detected for the c.896 þ 223A4G variant between extremely obese children and adolescents and normal weight adolescents (P ¼ 0.406, OR ¼ 1.154 (0.768-1.736)). Obese subjects with the GG genotype, however, had 30% increased fasting serum insulin levels (P ¼ 0.017) and increased degree of insulin resistance (P ¼ 0.025). There were in addition no differences in body mass index (BMI) or BMI standard deviation score (SDS) levels among the obese subjects according to genotype and the associations with insulin levels and insulin resistance remained significant when adjusting for BMI SDS. Conclusion: These findings suggest that this novel variant in FTO is affecting metabolic phenotypes such as insulin resistance, which are not mediated through differences in BMI levels.
Introduction
The global prevalence of obesity and overweight is increasing rapidly among children and adolescents. Although recent increases in obesity reflect lifestyle changes, genetic factors are also important in predisposing some individuals to obesity. 1, 2 Genome-wide association studies have revealed that variants in the first intronic region of FTO is associated with type 2 diabetes, which is abolished after adjustment for body mass index (BMI), suggesting that the increased risk of type 2 diabetes is entirely mediated through BMI. [3] [4] [5] Increased BMI levels and risk of obesity for FTO variants have been replicated in several cohorts consisting of adults 5 as well as adults and children. 3, 4, 6, 7 Associations between FTO variants and metabolic traits such as fasting insulin, glucose, cholesterol and triglycerides have also been found. These associations were, however, abolished when adjusting for BMI. 6, 8, 9 Although a large number of polymorphisms in FTO have been shown to be associated with obesity, none has been thoroughly investigated in terms of detailed phenotypic characteristic of metabolic conditions to elucidate the causative mechanisms or variants. The studies performed so far have, in addition, all been focused on known common variants. Here, we set out to investigate the effect of novel FTO variants on obesity prevalence and related metabolic traits. We identified a novel single nucleotide polymorphism (SNP) in FTO that is not associated with an increased risk of obesity but influence insulin levels and insulin resistance in children and adolescents with severe obesity.
Methods

Subjects
For the initial screening of FTO, we randomly selected 48 obese individuals out of 200. These 200 had been selected owing to their high BMI standard deviation score (SDS) levels and without any disease that can cause secondary obesity such as Prader Willi, Laurence-Moon Bardet-Biedl, Fragile-X, Morbus Down, melanocortin 4 receptor deficiency, psychological diagnoses such as developmental delay or other brain damages.
We further genotyped 962 children and adolescents comprising two study groups as described earlier.
10 Briefly
(1) one group of 450 obese children and adolescents (232 girls and 218 boys, age 6-21 years) enrolled at National Childhood Obesity Centre at Karolinska University Hospital, Huddinge, Sweden and (2) a group of 512 normal weight Swedish adolescents (268 girls and 244 boys, age 15-20 years) recruited from 17 upper secondary schools around Stockholm to match the obese group with respect to ethnicity and socioeconomic status. Subjects with overweight/obesity or chronic diseases were excluded from the group of normal weight adolescents, and subjects with type 2 diabetes were excluded from the obese group. The study was approved by the Regional Committee of Ethics, Stockholm.
Phenotype characterization
Birth weight and birth length were obtained from growth charts. Actual body weight and length were measured to the nearest 0.1 kg and 1 cm, respectively. BMI was calculated as body weight (kg) divided by squared height (m) and BMI SDS was calculated from weight, height, standardized for age and gender. 11 For the obese subjects, levels of plasma glucose, serum insulin, total triglycerides, total cholesterol and serum levels of triglycerides and cholesterol (high-density lipoprotein, low-density lipoprotein and very low-density lipoprotein) were analysed from blood samples drawn after 12-h overnight fasting. Insulin resistance index, HOMA, was calculated as fasting serum insulin (mU l
À1
) Â plasma glucose (mmol l À1 )/22.5. Insulin sensitivity index (S I ), glucose effectiveness (S G ) and acute insulin response (AIR) were calculated using the Bergman minimal model approach. 12 Hardy-Weinberg equilibrium. Genotype and allele frequencies among the obese and normal weight subjects were calculated and the difference in genotype frequency between the two groups was analysed with logistic regression, assuming an additive model, controlling for gender. Analysis of variance followed by Fisher's post hoc protected least significant difference (PLSD) test was used to examine phenotype differences between the genotype groups. Clinical variables were normalized when necessary by natural log transformation. Covariates such as birth weight, birth length, weight, length, gender, BMI SDS, Tanner stages and age were tested for dependence on the response variables and the effect of interaction between genotype and gender was included in the model. Clinical variables that were not possible to normalize were analysed with the non-parametric Kruskal-Wallis test. False discovery rate control for multiple testing was applied, considering the number of traits and models tested and a P-value o0.027 was considered significant. The analyses were performed with StatView version 5.0 (SAS Institute Inc., Cary, NC, USA).
Results
Two of the largest exons in FTO, exons 3 and 4 including exon-intron boundaries were screened in 48 obese children and adolescents. Three frequent and novel SNPs located in the fourth intron (c.896 þ 223A4G: AA 52%, AG 37.5%, GG 10.5%; c.896 þ 117C4G: CC 52%, CG 37.5%, GG 10.5%; c.896 þ 37A4G: AA 50%, AG 39.5%, GG 10.5%) were identified, which were all in strong linkage disequilibrium (r 2 ¼ 0.92). These SNPs were, however, not in linkage disequilibrium with the previously reported obesity-associated variant, rs9939609 (r 2 ¼ 0.06). The c.896 þ 223A4G
variant was further genotyped in 962 subjects and association with obesity and obesity-related traits were investigated. The overall genotyping success rate was 98.7% and the frequencies did not deviate from Hardy-Weinberg proportions (Table 1) . Evidence for differences in genotype frequencies was not detected for the c.896 þ 223A4G variant between extremely obese children and adolescents and normal weight adolescents (P ¼ 0.406, OR ¼ 1.154 (0.768-1.736)) ( Table 1) .
Differences in BMI and BMI SDS according to genotype among the normal weight adolescents were also analysed. G-allele carriers had increased levels when compared with the A-allele carriers; however, no significant differences were observed ( Table 2) .
Associations between c.896 þ 223A4G and obesity-related quantitative traits were investigated among the obese subjects ( Table 2) . No association was found between c.896 þ 223A4G and BMI (P ¼ 0.406) or BMI SDS (P ¼ 0.085). We found, however, an association with serum insulin levels and insulin resistance index, HOMA. Obese subjects with the GG genotype had about 30% increased fasting serum insulin levels (P ¼ 0.017) and degree of insulin resistance (P ¼ 0.025). Subjects with the G-allele had, in addition, increased plasma glucose levels, S G and AIR and decreased S I ; however, not significant. No differences between the genotypes were observed for triglycerides or cholesterol.
Because of genotype-gender interaction for insulin levels (P ¼ 0.009) and HOMA index (P ¼ 0.024), the present analyses were stratified for gender ( Table 2) . The unadjusted stratification analysis showed higher fasting serum insulin levels (P ¼ 0.0002) and increased degree of insulin resistance (P ¼ 0.001) for boys homozygous for the G-allele, with more than 60% increase when compared with A-allele homozygotes. These associations remained significant when adjusting for BMI SDS and age as well as after correction for multiple testing (fS-insulin P ¼ 0.0005, HOMA P ¼ 0.002). Among boys, we also observed decreased S I (P ¼ 0.007), with 45% lower sensitivity for GG homozygotes compared to A-allele carriers. In addition, borderline associations with increased plasma glucose levels (P ¼ 0.043) and AIR (P ¼ 0.039) were found. We did not observe any significant differences among girls; however, the same trends as seen among boys were observed for fasting serum insulin levels, HOMA and AIR ( Table 2) .
Discussion
FTO is a highly polymorphic gene, with over 1500 SNPs reported on the NCBI dbSNP build128. A cluster of variants in the first intron of FTO show strong and highly significant association with obesity and obesity-related traits in three independent genome-wide association studies, [3] [4] [5] findings that have been replicated in several other studies. [15] [16] [17] [18] In the present study, we identified three novel SNPs in the fourth intron, which are not in linkage disequilibrium with SNPs in the first intron, and examined the association between c.896 þ 223A4G and obesity as well as related phenotypes. Our study shows no increased risk of obesity for the novel variant and no significant differences in BMI or BMI SDS according to genotype among normal weight adolescents or among children and adolescents with severe obesity. Among adolescents with normal weight, G-allele carriers, however, had increased BMI SDS and it is possible that this variant has an effect on BMI in the general population, which is masked in subjects with severe obesity due to other genetic or environmental factors.
Among the obese subjects, we report an association between the c.896 þ 223A4G variant and serum insulin levels and insulin resistance, associations that remained significant after correction for BMI SDS. Thus, this FTO gene variant associates with other phenotypes when compared with previously studied FTO variants where the associations are almost exclusively mediated by differences in BMI. 6, 8, 9 The FTO gene encodes a probable 2-oxoglutarate-dependent nucleic acid demethylase 19 and is expressed in multiple peripheral and central tissues, 3, 20 which is characteristic for a gene that may display a pleiotropic character influencing several systems simultaneously. This suggests that FTO and polymorphism, such as c.896 þ 223A4G and rs9939609, that are not in linkage disequilibrium with each other may have different molecular effects on metabolic conditions and phenotypes. High levels of insulin and increased degree of insulin resistance have been implicated in both the causal mechanisms and the consequences of obesity. In total, 17% of the boys were homozygotes for the G-allele and had 60% increased fasting serum insulin levels as well as increased degree of insulin resistance and 45% decreased insulin sensitivity. Owing to the increased levels of insulin resistance observed for the GG homozygotes even when adjusting for BMI SDS, GG subjects seem to react with a more pronounced insulin resistance at the same degree of obesity than the A-allele carriers. Another explanation is that the increased insulin secretion causes obesity and secondary decreased insulin sensitivity. 21 However, this explanation is less likely because in that case one should have expected higher BMI levels among the obese GG carriers as well. In addition, the effect of this variant on insulin resistance might also be evident in normal weight subjects. We showed earlier that the FTO variant rs9939609 was associated with obesity and elevated BMI levels among homozygote girls, but not boys. 10 Although the phenotypic characteristics are different for this novel gene variant, the genotype-gender interactions found in the present study further points out that the FTO gene may act differently depending on gender. The best predictor of insulin sensitivity is body fatness, and changes in body composition are known to be gender specific, especially during early puberty, in concert with changes in the hormonal environment. Hormonal changes and puberty are also associated with increased insulin levels. 22 Owing to this, it is appealing to speculate that the gender-specific associations we found in the present study are due to some interaction between FTO and gender-specific mechanisms such as sex steroids.
In conclusion, this paper presents the identification of a novel variant in the FTO gene that do not seem to contribute to a higher risk of obesity. Obese individuals with the GG genotype, however, had significantly increased fasting serum insulin levels and increased degree of insulin resistance, which remained significant when adjusting for BMI SDS. Thus, it seems that this variant is affecting metabolic phenotypes such as insulin resistance, which is not mediated by differences in BMI.
